(Q30311102)

16 June 2017

1 reference

title

Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? (English)

1 reference

16 June 2017

1 reference

1 reference

Young S Hahn

1

1 reference

16 June 2017

publication date

1 August 2003

1 reference

Current Opinion in Immunology

16 June 2017

published in

1 reference

16 June 2017

volume

15

1 reference

16 June 2017

issue

4

1 reference

16 June 2017

page(s)

443-449

1 reference

Epidemiology of hepatitis C

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Identification of the major, parenteral non-A, non-B hepatitis agent (hepatitis C virus) using a recombinant cDNA approach

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Limited humoral immunity in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Cytotoxic T cells and viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein: intriguing properties and functional relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core particle detected by immunoelectron microscopy and optical rotation technique

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Complement component C1 and the collectins: parallels between routes of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

gC1q-R/p33, a member of a new class of multifunctional and multicompartmental cellular proteins, is involved in inflammation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Mechanism of suppression of cell-mediated immunity by measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

A truncated HCV core protein elicits a potent immune response with a strong participation of cellular immunity components in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

NK cells and NKT cells in innate defense against viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2803%2900076-1

7 January 2021

10.1016/S0952-7915(03)00076-1

Identifiers

DOI

1 reference

16 June 2017

1 reference